|
IVUS CHIP UPP Registry
RECRUITINGSponsored by ECRI bv
Actively Recruiting
SponsorECRI bv
Started2025-09-30
Est. completion2028-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations18 sites
View on ClinicalTrials.gov →
NCT06625801
Summary
The IVUS CHIP UPP Registry is a prospective, observational, multicenter, single-arm registry. A total of 1010 patients with complex coronary lesions will be enrolled in up to 2 years, with at least 500 men and women. All patients will be treated with IVUS-guided PCI.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. The patient must be ≥18 years of age and self-identify within a US census-defined minority 2. Patients with an indication for PCI of at least one lesion satisfying any of the following criteria: 1. Angiographic heavy calcification 2. Ostial lesions 3. True bifurcation lesions involving side-branches \>2.5mm 4. Left main lesions 5. Chronic total occlusion 6. In-stent restenosis 7. Long-lesions (estimated stent length \> 28mm) OR Patient with an indication for PCI for any lesion and in need for elective mechanical circulatory support assisted PCI 3. Presenting with silent ischemia, stable angina, unstable angina or non-ST-elevation acute coronary syndrome (NSTE-ACS) 4. All lesions must be suitable for treatment with FDA-approved contemporary generation drug eluting stents or drug-coated balloons 5. The patient is willing and able to cooperate with registry procedures and follow-up until registry completion 6. Subject is able to confirm understanding of risks, benefits and treatment alternatives and he/she (or an authorized legal representative) provides informed consent prior to any protocol-related procedure, as approved by the appropriate IRB Exclusion Criteria: 1. ST-elevation myocardial infarction or cardiogenic shock within prior 7 days 2. Known untreated severe valvular heart disease 3. Contraindication on the use of IVUS (i.e. extreme vessel tortuosity) 4. Requiring PCI in a diseased aorto-coronary bypass 5. Known contraindication or hypersensitivity to anticoagulants 6. Absolute contraindications or allergy that cannot be pre-medicated, to iodinated contrast or to antiplatelet drugs, including both aspirin and P2Y12 inhibitors 7. Non-cardiac co-morbidities with a life expectancy less than 1 year 8. A patients that is currently participating in a clinical trial that has not yet reached its primary endpoint cannot be included in this registry. A patient may only be enrolled in this registry once.
Conditions4
Complex Coronary Artery DiseaseCoronary Artery DiseaseCoronary Artery Disease Risk HighHeart Disease
Locations18 sites
Find trials near these locations
Heart Disease trials in PhoenixHeart Disease trials in OrlandoHeart Disease trials in TampaHeart Disease trials in AtlantaHeart Disease trials in ChicagoHeart Disease trials in LouisvilleAll trials in ArizonaAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in KentuckyAll trials in MichiganAll trials in MinnesotaAll trials in MississippiAll trials in New JerseyAll trials in Rhode Island
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorECRI bv
Started2025-09-30
Est. completion2028-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations18 sites
View on ClinicalTrials.gov →
NCT06625801